Indomethacin-induced HL-60 leukemic cell apoptosis and the activation of C-Jun NH2-terminal kinase signal transduction pathway

Bulletin of Hunan Medical University

Volumn 28, Issue 6, 2003, Pages 557-562

  Zhang, Guang Sen ^a   Liu, Ding Sheng ^a   Xia, Meng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase activation; HL 60 cell line; Indomethacin; MEK JNK signal transduction pathway

Indexed keywords

CASPASE 3; CASPASE 9; INDOMETACIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HL 60; CONCENTRATION RESPONSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

APOPTOSIS; CASPASE 3; CASPASE 9; CASPASES; CELL DIVISION; HL-60 CELLS; HUMANS; INDOMETHACIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 2142766979     PISSN: 10005625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Shiff SJ, Qial L, Tsai LL, et al. Sulindac Sulfide, an aspirin-like compound, inhibits proliferation, causes cell quiescence and induce apoptosis in HT-29 colon adenocarcinoma cells[J]. J Clin Invest, 1995, 96(1): 491-503.
2. Zhang GS, Tu CQ, Zhang GY, et al. Indomethacin induces apoptosis and inhibits proliferation in chronic myeloid leukemia cells[J]. Leukemia Res, 2000, 24(5): 385-392.
3. Chan-Hui PY, Weaver R. Human mitogen-activated protein kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades[J]. Biochem J, 1998, 336(Pt 3): 599-609.
4. Ichijo H. From receptors to stress-activated MAP kinases[J]. Oncogene, 1999, 18(45): 6087-6093.
5. IP YT, Davis RJ. Signal transduction by the C-Jun N-terminal kinase (JNK)-from inflammation to development[J]. Curr Opin Cell Biol, 1998, 10(2): 205-219.
6. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer[J]. Cancer Res, 1995, 55(17): 3785-3789.
7. DuBois RN. Selective COX-2 inhibitors: potential for cancer prevention and treatment [A]. In: 93 rd Annual meeting, American Association for Cancer Research[C]. San Francisco, Program/proceedings supplement, 2002, 46.
8. Tourneir C, Hess P, Yang DD, et al. Requirement of JNK for stress-induced activation of the cytochrome C-mediated death pathway[J]. Science, 2000, 288(5467): 870-874.
9. Seimiya H, Mashima T, Toho M, et al. C-Jun NH2-terminal kinase-mediated activation of interleukin-1 beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis[J]. J Biol Chem, 1997, 272(7): 4631-4636.
10. Mc Gee MM, Campiani G, Ramunno A, et al. Activation of the C-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells[J]. J Biol Chem, 2002, 277(21): 18383-18389.